Dr. Ginger L. Degravelle, MD

Dr. Degravelle practices at Adventist Health Portland in Portland, Oregon, part of Adventist Health.

Dr. Degravelle's NPI, 1205362944, was assigned on May 1, 2017. Dr. Degravelle graduated from LSU Health Shreveport School of Medicine in 2017. Dr. Degravelle's Oregon license number on file is MD217089.

Dr. Degravelle's primary practice is Adventist Health Portland, at 10123 Se Market Street, Portland, OR 97216 in Multnomah County. The practice phone is (503) 257-2500.

Dr. Degravelle's primary practice is Adventist Health Portland in Portland, Oregon, part of Adventist Health. Dr. Degravelle is also affiliated with OHSU Hospital. The medical group on file is Adventist Health Portland. Dmand AI also links Dr. Degravelle to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Degravelle practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Degravelle's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Degravelle is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Degravelle's licenses on file in 3 states: Oregon, Alabama and Virginia.

Dmand AI lists irritable bowel syndrome (IBS) among the conditions Dr. Degravelle treats.

CMS data shows 256 Medicare services from Dr. Degravelle across 8 procedure codes in 2024, for 160 Medicare patients. Medicare paid $23,472 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 160 Medicare patients who saw Dr. Degravelle in 2024. The largest group is 65 to 74, with 88 patients. 74% of them have high blood pressure, and 70% have high cholesterol. 26% are also on Medicaid. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Degravelle's median patient age at 70, with 62% women.

In 2024, Dr. Degravelle wrote 550 Medicare Part D claims for 178 patients. 90% of them were for generic drugs. CMS names the drug for 460 of them, across 16 drugs with 11 or more claims each, at $8,996 in total drug cost. In 2023, CMS named 31 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Degravelle for performance year 2024, reported as part of a group. Dr. Degravelle accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Degravelle as offering telehealth. CMS counts 34 procedures of colonoscopy by Dr. Degravelle, more than 56% of the clinicians it reports for that procedure.

CMS Open Payments shows 14 general payments to Dr. Degravelle from 7 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $412.

Dr. Degravelle graduated from LSU Health Shreveport School of Medicine in 2017.

Dr. Degravelle is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.